Denali Therapeutics Inc. Common Stock
£14.4
GBP
Last updated on --.
24h volume14.68K
24h highest14.8901 GBP
24h lowest14.2393 GBP
24h Price movement-0.05%
DNLI recent prices
24 Hours
-0.05%-£0.007438
30 days
-2.86%-£0.42397
60 days
+2.64%+£0.35702
90 days
-9.57%-£1.525
Key data
Previous close14.4148 GBP
Market cap2.22B GBP
Volume14.68K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.3876 GBP
Net income (FY)-377.86M GBP
Revenue (FY)--
Last report dateMay 7, 2026
About Denali Therapeutics Inc. Common Stock
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)507.00
Net income per employee (FY)-745.29K GBP
Listed onNasdaq
DNLI conversion tables
 |  |
|---|---|
| 0.5 DNLI | 7.203 GBP |
| 1 DNLI | 14.4 GBP |
| 5 DNLI | 72.03 GBP |
| 10 DNLI | 144.07 GBP |
| |
|---|---|
| 0.5 GBP | 0.034704 DNLI |
| 1 GBP | 0.069409 DNLI |
| 5 GBP | 0.34704 DNLI |
| 10 GBP | 0.69409 DNLI |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
DNLI is trading at £14.40, -0.05% over the last 24 hours. Track live moves on the price chart at the top of this page.
The DNLI stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. DNLI is currently trading at £14.40, -0.05% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on DNLI price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. DNLI's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from DNLI; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against DNLI's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Denali Therapeutics Inc. Common Stock's market cap is currently 2.22B GBP. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume14.68K
24h highest14.8901 GBP
24h lowest14.2393 GBP
24h Price movement-0.05%
Start trade with DNLI Perpetual
Sign up to trade